SG
MDCO

Societe Generale’s Medicines Co MDCO Stock Holding History

Societe Generale’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$947K Buy
+28,159
New +$993K 0.01% 1334

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Societe Generale's MDCO Position: Q2 2016 in Review

Societe Generale opened a new position in Medicines Co (MDCO) in Q2 2016: 28,159 shares worth $947K. The stake represents 0.01% of the portfolio and ranks #1334 among its holdings.

190 funds tracked by Wall St. Rank hold MDCO as of Q2 2016.

  • Societe Generale held 28,159 shares of Medicines Co worth $947K as of Q2 2016.
  • Medicines Co was a new Societe Generale position in Q2 2016.
  • Medicines Co made up 0.01% of Societe Generale's portfolio in Q2 2016, its #1334 holding.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.